ÂÜÀòÂÒÂ×

Susan E. Graf is the Chief Executive Officer of Akamara Therapeutics. Previously, Susan was Chief Business Officer and Principal Financial Officer at Epizyme. Prior to Epizyme, Susan held the position of Vice President, Corporate Development and Strategy for NPS Pharma before it was acquired by the Shire in 2015. Prior to NPS Pharma, Susan spent nearly 18 years at Roche in a number of leadership and executive positions.

Susan has an MBA from the Stern School of Business at New York University, and a Bachelor of Pharmacy degree from Purdue University.